RECRUITING

Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

With modern therapy, the survival rate for pediatric brain tumor patients has significantly improved, with over 70% of patients surviving their disease. However, this progress often comes at the cost of substantial morbidity, with cognitive deficits being the primary obstacle to independent living. Robust predictors of cognitive decline and a comprehensive understanding of the underlying mechanisms of cognitive injury remain elusive. This study will prospectively investigate alterations in brain resting state networks following radiation therapy using functional imaging. The hypothesis is that radiation therapy leads to dose-dependent alterations in functional connectivity in the networks associated with higher level cognition, ultimately leading to cognitive decline.

Official Title

Assessing Radiation Induced Alterations in Resting State Brain Networks in Pediatric Brain Tumor Patients

Quick Facts

Study Start:2024-07-10
Study Completion:2027-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06185686

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:8 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Between 8 and 21 years of age, inclusive
  2. * Newly diagnosed primary brain tumor of any location and any histology that will be treated with proton radiation therapy
  3. * Life expectancy of at least one year
  4. * Able to understand and willing to consent or assent to the research proposed (or that of a legally authorized representative, if applicable), along with consent of legal guardian(s) if applicable
  1. * Presence of visual impairment to an extent that the patient is unable to complete the computer testing
  2. * Contraindication to MRI scan (i.e. due to cardiac pacemaker)
  3. * Presence of programmable shunt or dental braces
  4. * Requires sedation for MRI scans

Contacts and Locations

Study Contact

Stephanie Perkins, M.D.
CONTACT
314-747-4405
sperkins@wustl.edu

Principal Investigator

Stephanie Perkins, M.D.
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

Washington University School of Medicine/Saint Louis Children's Hospital
Saint Louis, Missouri, 63110
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Stephanie Perkins, M.D., PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-10
Study Completion Date2027-07-31

Study Record Updates

Study Start Date2024-07-10
Study Completion Date2027-07-31

Terms related to this study

Keywords Provided by Researchers

  • Proton therapy
  • Radiation
  • Brain tumor

Additional Relevant MeSH Terms

  • Brain Tumor, Primary